Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
'Highway robbery': Critics blast VP Harris for 'violating' Medicare trust fund
Vice President Kamala Harris faces criticism for pledging to secure the Medicare trust fund while the Biden/Harris administration seeks to use it to offset premium hikes.
Dr. Marc Siegel details impact of port strike on medication: This is life saving stuff
Fox News senior medical analyst Dr. Marc Siegel discusses HHS declaring a public health emergency in North Carolina, the impact of the port strike on medical supply imports and toxic flame retardants found in plastic utensils.
How could the port strike impact the delivery of crucial medication?
Fox News senior medical analyst Dr. Marc Siegel says the strike is a 'major disaster' for the United States on 'The Bottom Line' (Courtesy: CBS News).
Port strike could delay delivery of critical medications: It could be 'devastating,' doctors say
Medical professionals are sounding the alarm over the potential impact prolonged port strikes along the East and Gulf coasts can have on medical supplies.
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Expert says Medicaid, Medicare reform is critical and can save $2.1 trillion
Surging federal spending on health care programs like Medicare and Medicaid, as well as ObamaCare, prompted Paragon's plan to curb spending by an estimated $2.1 trillion over 10 years.
Expert discusses need for federal health care policy reforms
Paragon Health Institute's Brian Blase discusses strategies for reforming major federal health care programs.
The 'dogma' of modern medicine has done 'tremendous damage' to America's public health: Dr. Marty Makary
Johns Hopkins professor and 'Blind Spots' author Dr. Marty Makary analyzes the state of public health in America and chronic disease concerns.
J&J subsidiary files for bankruptcy again to settle talc lawsuits
A Johnson & Johnson subsidiary filed bankruptcy for the third time in an ongoing effort to settle tens of thousands of lawsuits that claims certain J&J products cause cancer.
Baby powder sold on Amazon recalled due to potential asbestos contamination
Dynarex Corp. is recalling 62 cases of its Dynacare Baby Powder after sample testing revealed that the finished product contained asbestos, a known carcinogen.
Pesticides in our food have become a ‘blind spot’ in our health: Dr. Marty Makary
Johns Hopkins School of Medicine professor Dr. Marty Makary reacts to a new report revealing that cancer deaths in the U.S. fell by 33% in 30 years.
AI-powered app offers personalized allergy forecasts
SoundHealth launched a new feature in its AI-powered health care app that will give users personalized allergy forecasts to get ahead of their symptoms.
Merck could see double-digit stock price increases in next 5 years: Jacob Sonenshine
Barron's market reporter Jacob Sonenshine breaks down the market as the Fed meeting kicks off and spotlights pharmaceutical company Merck.
Dr. Marty Makary addresses 'root issues' of health inequities
Johns Hopkins School of Medicine professor Dr. Marty Makary details his new book, 'Blind Spots,' and reacts to a rising concerns around energy drinks and chronic diseases.
Walgreens to pay $106.8M over claims it billed government for prescriptions never dispensed
Walgreens has agreed to pay a $106.8 million fine to settle the Department of Justice's claims the pharmacy billed the government for prescriptions that were never dispensed.
Inside the production pipeline for new drugs to combat heart failure
Cardiol Therapeutics Inc. President and CEO David Elsley discusses the rise in heart failure deaths among young adults on 'Making Money.'
Study: COVID accelerated aging in teens' brains
Johns Hopkins School of Medicine professor Dr. Marty Makary joins 'Varney & Co.' to discuss a new study that shows the impact the COVID pandemic had on teenagers' brains.
Weight-loss drugs and children: What doctors say about the safety, effectiveness of the medications
Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being tested on children as young as six years old.
Apple's new AirPods Pro double as hearing aids
Apple's next generation of AirPods Pro offers a hearing aid feature for users with mild to moderate hearing loss, which could be a game changer for some users.